Answers are grounded in this paper and cite their sources.
This research uncovers the role of COLEC12high TAMs in therapeutic resistance in HCC, suggesting new strategies for treatment.
Our work establishes the COLEC12high TAM / NRG1 axis as a master regulator of therapeutic resistance and identifies NRG1 as a predictive biomarker, providing a clinically actionable strategy to overcome lenvatinib resistance in HCC.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: